Last reviewed · How we verify

NCT04149028

Platelet Rich Plasma Injection Into Ovary of Patients With Premature Ovarian Insufficiency

Completed NA Last updated 17 February 2023
What this trial tests

NA trial testing PRP injection inside the ovary by laparoscoy. The injection volume is 2 ml in Premature Ovarian Failure in 16 participants. Completed in 31 December 2022.

Timeline
1 December 2019
Primary endpoint
31 December 2022
31 December 2022

Quick facts

Lead sponsorTanta University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment16
Start date1 December 2019
Primary completion31 December 2022
Estimated completion31 December 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Tanta University

Who can join

Adults 18 to 35, female only, with Premature Ovarian Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

All encountered cases with POI will be assessed and examined then investigated. Eligible cases will be included in the study

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Therapeutic roles of platelet-rich plasma to restore female reproductive and endocrine dysfunction.
    Wang X, Li J, Lu W, Gao F, et al · · 2024 · cited 8× · PMID 38654928 · DOI 10.3389/fendo.2024.1374382
  2. Platelet-Rich Plasma (PRP) in Reproductive Medicine: A Critical Review of PRP Therapy in Low-Reserve and Premature Ovarian Insufficiency.
    Moustakli E, Potiris A, Zikopoulos A, Zachariou A, et al · · 2025 · cited 2× · PMID 40427083 · DOI 10.3390/biomedicines13051257
  3. Research trends on platelet-rich plasma in improving ovarian dysfunction: A bibliometric and visualization analysis.
    Liu F, Li J, Li J, Lan M, et al · · 2025 · PMID 41079455 · DOI 10.1016/j.reth.2025.09.010

Verify or expand the search:

Other recruiting trials for Premature Ovarian Failure

Currently open trials in the same condition.

Other Tanta University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04149028.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing